Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist

Blood. 1994 Dec 15;84(12):4142-50.

Abstract

We investigated the effects of interferon-alpha (IFN-alpha) on the expression of cytokines by human bone marrow stromal cells. Production of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte-CSF (G-CSF), and interleukin-1 beta (IL-1 beta) in stromal cell layers was induced by incubation with IL-1 alpha, tumor necrosis factor (TNF), or lipopolysaccharide (LPS). Addition of IFN-alpha to such stimulated cultures resulted in a strong downregulation of mRNA expression of GM-CSF and IL-1 beta. Similarly, the protein levels of GM-CSF and IL-1 beta were significantly reduced by IFN-alpha, whereas G-CSF production was only moderately inhibited. In contrast, IFN-alpha markedly stimulated the production of IL-1 receptor antagonist (IL-1RA) by stromal cells. The inhibition of cytokine expression resulted in a reduced hematopoietic activity of stromal cells, indicated by a reduced proliferation of the factor dependent cell line MO7e on IFN-alpha-treated stromal cells. In the presence of cycloheximide (CHX), IFN-alpha failed to inhibit IL-1 mRNA expression, whereas the regulation of GM-CSF and IL-1RA by IFN-alpha was not affected. Our results indicate that the myelosuppressive effects of IFN-alpha, as observed in therapeutic applications or associated with viral infections, are, in part, indirectly mediated by inhibition of the paracrine production of hematopoietic growth factors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Bone Marrow / drug effects*
  • Bone Marrow Cells
  • Cell Line
  • Cells, Cultured
  • Connective Tissue / drug effects*
  • Connective Tissue / metabolism
  • Cycloheximide / pharmacology
  • Cytokines / biosynthesis*
  • Cytokines / genetics
  • Dactinomycin / pharmacology
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Gene Expression Regulation / drug effects*
  • Hematopoiesis / drug effects
  • Hematopoietic Cell Growth Factors / antagonists & inhibitors*
  • Hematopoietic Cell Growth Factors / biosynthesis
  • Hematopoietic Cell Growth Factors / genetics
  • Hematopoietic Cell Growth Factors / pharmacology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / pharmacology*
  • Interleukin 1 Receptor Antagonist Protein
  • Molecular Sequence Data
  • Receptors, Interleukin-1 / antagonists & inhibitors*
  • Recombinant Proteins / pharmacology
  • Sialoglycoproteins / biosynthesis*
  • Sialoglycoproteins / genetics
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Cytokines
  • Hematopoietic Cell Growth Factors
  • IL1RN protein, human
  • Interferon alpha-2
  • Interferon-alpha
  • Interleukin 1 Receptor Antagonist Protein
  • Receptors, Interleukin-1
  • Recombinant Proteins
  • Sialoglycoproteins
  • Tumor Necrosis Factor-alpha
  • Dactinomycin
  • Cycloheximide